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Background: Dual oxidase (Duox)-Duox activator (DuoxA) complexes produce H2O2, not O2. , suggesting that specialized
mechanisms convert O2. to H2O2.
Results: In comparison with Duox2, Duox1 prevents O2. leakage more stringently.
Conclusion: Duox A-loops function in reducing O2. release by promoting the stabilization and maturation of Duox-DuoxA
complexes.
Significance: The mechanism underlying H2O2 production by Duoxes has been clarified.
NADPH oxidase (Nox) family proteins produce superoxide
(O2.) directly by transferring an electron to molecular oxygen.
Dual oxidases (Duoxes) also produce an O2. intermediate,
although the final species secreted by mature Duoxes is H2O2,
suggesting that intramolecular O2. dismutation or other mecha-
nisms contribute to H2O2 release. We explored the structural
determinants affecting reactive oxygen species formation by
Duox enzymes. Duox2 showed O2. leakage when mismatched
with Duox activator 1 (DuoxA1). Duox2 released O2. even in
correctly matched combinations, including Duox2  DuoxA2
and Duox2  N-terminally tagged DuoxA2 regardless of the
type or number of tags. Conversely, Duox1 did not release O2. in
any combination. Chimeric Duox2 possessing the A-loop of
Duox1 showed no O2. leakage; chimeric Duox1 possessing the
A-loop of Duox2 released O2.. Moreover, Duox2 proteins pos-
sessing theA-loops of Nox1 orNox5 co-expressedwithDuoxA2
showedenhancedO2. release, andDuox1proteins possessing the
A-loops of Nox1 or Nox5 co-expressed with DuoxA1 acquired
O2. leakage. Although we identified Duox1 A-loop residues
(His1071, His1072, and Gly1074) important for reducing O2.
release, mutations of these residues to those of Duox2 failed to
convert Duox1 to an O2.-releasing enzyme. Using immunopre-
cipitation and endoglycosidase H sensitivity assays, we found
that the A-loop of Duoxes binds to DuoxA N termini, creating
more stable, mature Duox-DuoxA complexes. In conclusion,
the A-loops of both Duoxes support H2O2 production through
interaction with corresponding activators, but complex forma-
tion between the Duox1 A-loop and DuoxA1 results in tighter
control of H2O2 release by the enzyme complex.
Dual oxidases (Duoxes3; Duox1 and Duox2) are members of
the NADPH oxidase (Nox) family proteins (Nox1–5 and
Duoxes) that produce reactive oxygen species (ROS) (1–3).
Duox1 (4) and Duox2 (5) are functional only in combination
with maturation factors known as Duox activators (DuoxAs;
DuoxA1 and DuoxA2) (6). Although DuoxAs were first
described as factors required to permitDuoxes to exit the endo-
plasmic reticulum, it was later reported that Duox and DuoxA
proteins form stable heterodimers and co-translocate to the
plasma membrane (7). Both Duoxes were first characterized as
thyroid oxidases supporting thyroid hormone biosynthesis,
although Duox2 is the dominant form, with an expression level
five times higher than that of Duox1 in thyroid tissue (8).More-
over, mutations or deficiencies in Duox2 or DuoxA2 have been
reported to cause congenital hypothyroidism in mice (9, 10)
and humans (8), whereas deficiency in Duox1 has no effect on
thyroid hormone levels inDuox1 knock-outmice (11). Bi-allelic
mutations in Duox2 reportedly cause transient congenital
hypothyroidism, suggesting that some compensation occurs
by Duox1 (12). More recently, a patient with transient con-
genital hypothyroidism was described; this patient was com-
pound heterozygous for a large deletion comprising DUOX2,
DUOXA2, and DUOXA1 and a nonfunctional missense muta-
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tion of DUOXA2 in the other allele, suggesting compensation
by the remaining Duox1-DuoxA1 complex or by the mis-
matched Duox2-DuoxA1 complex (13).
In addition, Duox enzymes have been detected and believed
to function on the epithelial cell surfaces of mucosal and exo-
crine tissues (2, 14–16), including the airways and gastrointes-
tinal tract. In these tissues, Duoxes also function in host defense
against a broad spectrum of pathogens (17–19). Nox family
proteins produce the primary product superoxide (O2. ) by
directly transferring an electron to molecular oxygen (2, 20).
Duoxes produce O2. as an intermediate product (21), but the
final product generated by mature Duoxes is H2O2, suggesting
that intramolecular O2. dismutation or other mechanisms con-
tribute to H2O2 release (2). In tissues with high Duox expres-
sion, the enzymes accumulate on the apical plasmamembrane,
facilitatingH2O2 release from epithelial cell surfaces to support
the activities of extracellular hemoperoxidases (22).
In contrast to Nox1–5, Duoxes have an extendedN-terminal
extracellular domain called the peroxidase homology (PoxH)
domain, followed by an additional transmembrane (TM) seg-
ment and an intracellular loop containing two calcium-binding
EF-hand motifs (4, 23) (Fig. 1A). Thus, Duoxes possess four
extracellular regions: the PoxHdomain (1–595 amino acids (aa)
in human Duox2) and three loops (the A-loop, 1064–1078 aa;
C-loop, 1146–1184 aa; E-loop, 1242–1251 aa in humanDuox2)
(Fig. 1A). The PoxH domain is a candidate for intramolecular
O2. dismutation, although the isolated PoxH domains of both
Duoxes demonstrate no O2. dismutation activity in vitro (24,
25). Thus, the mechanism underlying H2O2 production by
Duoxes remains poorly understood.
A switch in ROS generation from H2O2 to O2. occurs when
Duox2 is mismatched with DuoxA1 (26). We reported that the
mismatched combination of Duox2DuoxA1, but not that of
Duox1  DuoxA2, releases O2. in addition to H2O2; we called
this phenomenon O2. leakage (7). In this study we examined
why Duox2, but not Duox1, leaks O2. , in addition to exploring
the structural features of Duox andDuoxA proteins involved in
H2O2 release. We found that the A-loops of Duoxes, particu-
larly Duox1, function in controlling O2. release by contributing
to the stabilization andmaturation of Duox-DuoxA complexes.
EXPERIMENTAL PROCEDURES
Materials—A polyclonal antibody (pAb) against Duoxes,
which preferentially detects Duox2 via the first intracellular
loop (639–1039 aa of human Duox2) but also detects Duox1,
was previously described (15). A pAb against DuoxA1, which
recognizes the extracellular N terminus of DuoxA1, was
obtained from Santa Cruz Biotechnology, Inc. Unfortunately,
no commercial Ab against DuoxA2 for immunoblotting or
immunostaining is available. mAbs against HA(TANA2)-con-
jugated HRP, Alexa Fluor 488, and magnetic agarose were
obtained from MBL International Corp. An mAb against
FLAG(M2)-conjugated HRP was obtained from Sigma.
Endoglycosidase H (Endo H) was obtained from New England
Biolabs.
Cell Culture—HEK293 cells (ATCC) were maintained in
Eagle’s minimal essential medium (Wako Pure Chemical
Industries) containing 10% FBS (Nichirei Biosciences), 100 M
nonessential aa (Wako Pure Chemical Industries), and antibi-
otics at 37 °C in 5% CO2.
Construction of Plasmids—We used human Duox2, DuoxA1(),
and DuoxA2 in pcDNA3.1 (Invitrogen), which were previously
described (7). Human Duox1 cDNA was a kind gift from Dr.
Francoise Miot (Université Libre de Bruxelles, Brussels, Bel-
gium) (4) and was transferred into pcDNA3.1. Duox1 and
Duox2 with a 2HA tag between Asn-23 and Pro-24 and
between Asp-27 and Ala-28, respectively, in the first extracel-
lular region were created in pcDNA3.1 by site-directed
mutagenesis using a QuikChange Lightening Site-Directed
Mutagenesis kit (Agilent Technologies). The chimeric con-
struct Duox(1PoxH-2), possessing the PoxH domain of Duox1
(1–592 aa) and the Nox-like portion of Duox2 (596–1548 aa),
and the chimeric construct Duox(2PoxH-1), possessing the
PoxH domain of Duox2 (1–594 aa) and the Nox-like portion of
Duox1 (592–1551 aa), were created in pcDNA3.1 by PCR
and restriction enzyme-based recombination. DuoxA1 and
DuoxA2 in both p3FLAG-CMV-10 (Sigma) and p3FLAG-
CMV-14 (Sigma-Aldrich) vectors were made using PCR and
named 3NFLAG-DuoxA1, 3NFLAG-DuoxA2, DuoxA1–
3CFLAG, and DuoxA2–3CFLAG. DuoxA2 with 2FLAG
and DuoxA2 with 1FLAG at the N terminus were made by
QuikChange using 3NFLAG-DuoxA2 as a template. DuoxA2
with 2HA at the N terminus was made by QuikChange using
DuoxA2 as a template. DuoxA1 with 1FLAG at the C termi-
nus was made by QuikChange using DuoxA1–3CFLAG as a
template. The chimeric construct DuoxA(1-2), possessing the
N-terminal extracellular region of DuoxA1 (1–19 aa) and
DuoxA2 (20–320 aa), and the chimeric construct DuoxA(2-1),
FIGURE 1. Sequence alignment of the three extracellular loops of Duox1
and Duox2. Schematic illustration of a Duox (A) and amino acid sequence
alignment of the three extracellular loops (A, C, andE) ofDuox1 andDuox2 (B)
(4, 23). Superscript and subscript numbers represent amino acid sequence
numbers.Underlined residuesdenote differences betweenDuox1 andDuox2.
Role of Duox A-loops in H2O2 Release
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possessing the N-terminal extracellular region of DuoxA2
(1–19 aa) and DuoxA1 (20–343 aa), were created in pcDNA3.1
usingPCR.N-terminal deletion (2–17aa)mutants ofDuoxA1and
DuoxA2 were generated using PCR and named DuoxA1(N-del)
and DuoxA2(N-del). All other mutants/chimeric constructs of
Duox and DuoxA, including Duox231(A:8aa), Duox231(C:10aa),
Duox231(E:TY/RF), Duox132(A:8aaL), Duox13Nox1(A),
Duox13Nox5(A), Duox23Nox1(A), Duox23Nox5(A), DuoxA-
(1F-2), andDuoxA(2-1S-2),weremadebyQuikChange.These are
named and described inTable 1 and are illustrated in Figs. 3A, 4A,
5A, 7A, 7C, and 8A. All plasmids were sequenced to confirm their
identities.
In Vitro Binding (Pulldown) Assays—Forward and reverse
oligonucleotides for DuoxA N terminus (1–20 aa for DuoxA1
or 1–19 aa for DuoxA2) were annealed and cloned into the
BamHI and EcoRI sites of pGEX-6P-1. Purified GST and GST-
tagged DuoxAN-terminal proteins (DuoxA1(N), GST-MATL-
GHTFPFYAGPKPTFP; DuoxA2(N), GST-MTLWNGVLPF-
YPQPRHAAG) were obtained as described previously (27).
Biotin-labeled Duox A-loop peptides (Duox1(Aloop), biotin-
AAHHTGITDTTRV; Duox2(Aloop), biotin-ALPPSDIAQT-
TLV) were synthesized by MBL International. GST-tagged
DuoxA(N) was mixed with biotin-labeled Duox(Aloop) in 300
l of binding buffer (500 nM each) (27). After rotation for 2 h at
4 °C, 40 l of streptavidin-coupled magnetic beads (Dynabeads
M-280 Streptavidin; Invitrogen) were added to the solution,
and the mixture was agitated for 90 min at 4 °C. The precipi-
tates were washed 3 times using a magnetic rack, and then the
material absorbed to the beads was eluted in Laemmli sample
buffer; themagnetic beadswere then removed using amagnetic
rack. The eluents were subjected to SDS-PAGE followed by
immunoblotting using a polyclonal antibody against GST
(Santa Cruz Biotechnology). Bound antibodies were detected
with an HRP-conjugated secondary antibody using the ECL
detection system (GE Healthcare).
Immunoprecipitation and Immunoblotting—Various pairs of
2HA-Duox and FLAG-tagged DuoxA constructs were
co-transfected into HEK293 cells plated on 10-cm dishes using
FuGENE 6 (Promega). Forty-eight hours after transfection, the
cells were lysed in 250l of lysis buffer with a protease inhibitor
mixture (27) by sonication. Total cell lysates were centrifuged
at 800  g for 5 min at 4 °C, and the supernatants were incu-
bated with 10 l of magnetic agarose-conjugated HA mAb for
2 h at 4 °C. The precipitates were washed 3 times, and aliquots
of the precipitates were subjected to SDS-PAGE followed by
immunoblotting using an HRP-conjugated FLAG mAb and
detected using the ECL detection system.
N-Deglycosylation Analysis—The deglycosylation assay was
performed as previously described (7). Briefly, various pairs of
2HA-Duox and DuoxA constructs were co-transfected into
HEK293 cells plated in 10-cm dishes using FuGENE 6. Forty-
eight hours after transfection, the cells were lysed in 250 l of
lysis buffer with a protease inhibitor mixture. After centrifuga-
tion at 12,000 g for 10 min at 4 °C, equal amounts of proteins
were treated with 100 units/50l of EndoH for 30min at 37 °C
or left untreated and separated by SDS-PAGE. Immunoblotting
was performed using an HRP-conjugated HA mAb.
Confocal Fluorescence Imaging Studies—A total of 2.5 105
HEK293 cells were seeded in 35-mm glass-bottomed dishes
(MatTek Corp.) 48 h before transfection and transfected using
FuGENE 6. Thirty-two hours after transfection, the cells were
fixed using 4% paraformaldehyde in 0.1 M PBS (pH 7.4) without
permeabilization and stained using an Alexa Fluor 488-conju-
gated HA mAb (1:500) at room temperature for 2 h for visual-
ization by confocal laser scanning fluorescence microscopy
(LSM700; Carl Zeiss AG). All imaging experiments were per-
formed in triplicate and were repeated in at least three inde-
pendent transfection experiments (n 9).
ROS Production Assay—HEK293 cells were seeded in 6-well
dishes at 2.5 105 cells/well 48 h before transfection. HEK293
cells were transfected using FuGENE 6 in complexes with var-
ious combinations of plasmids. The cells were fed 6 h post-
transfection with complete medium and harvested using 0.02%
EDTA solution (Nacalai Tesque). Thirty-two hours after trans-
fection, 2  105 cells in Hank’s balanced salt solution
(HBSS();Wako Pure Chemical Industries) were used for ROS
assays with 0.2 M ionomycin (Sigma) 2 mMCa2. Chemilu-
minescence methods were used in the presence of luminol 
HRP (Sigma) for gross ROS detection (H2O2, O2. , and other
non-identified ROS), superoxide dismutase-inhibitable Dioge-
nes reagent (National Diagnostics) for O2. detection, or Amplex
Red (Invitrogen)HRP for H2O2 detection for 10 min using a
luminometer (Mithras LB940; Berthold Detection Systems
GmbH) (28) as previously described (7, 29). O2. production
from 5  105 cells in 100 l of HBSS() stimulated by 0.2 M
ionomycin 2 mMCa2was also measured based on the assay
of cytochrome c (100M, Sigma) reductionwith amolar extinc-
tion coefficient of 21 mM1 cm1 at 550 nm using a mono-
chrometer (Multiskan GO; Thermo Fisher Scientific) as previ-
ously described (7, 30). O2. production was inhibited by the
addition of 10 units/ml superoxide dismutase (Sigma) in the
assay solution. Comparable expression of proteins was con-
firmed by immunoblotting using total lysates from the same
number of cells.Mean oxidase activitieswere calculated fromat
least three independent transfection experiments.
Statistical Analysis—All data are presented as the means 
S.E. of mean. For comparisons of more than two groups, one-
way analysis of variance was performed. Statistical analyses
were performed usingGraphPad Prism 5.0 software (GraphPad
Software Inc.); p 0.05 was considered statistically significant.
RESULTS
Tags at the N terminus of DuoxA2 Enhance O2. Leakage from
Matched Duox2-DuoxA2 Complexes—We previously demon-
strated that co-expression of the mismatched Duox2 and
DuoxA1, but not of Duox1 andDuoxA2, causesO2. leakage into
the extracellular milieu (7). In this study we found that co-ex-
pression ofmatchedDuox2 andDuoxA2, but not of Duox1 and
DuoxA1, caused a small amount of O2. release (5.4  0.6%)
detected by Diogenes; this is consistent with the result of a
previous report (31). To elucidate why only Duox2- and not
Duox1-based combinations cause extracellular O2. release, we
created a series of N-terminally FLAG-tagged DuoxA1 and
DuoxA2 constructs (Table 1). Interestingly, although C-termi-
nally 3FLAG-tagged DuoxA2 co-expressed with Duox2 did
Role of Duox A-loops in H2O2 Release
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not enhance O2. release, N-terminally tagged DuoxA2 dramat-
ically enhanced the amount ofO2. release regardless of the num-
ber or type of epitope tags (Fig. 2A; 3NFLAG, 291.2 36.5%;
2NFLAG, 387.4 9.1%; 1NFLAG, 543.9 66.9%; 2NHA,
465.4  67.8%). Duox1 exhibited no O2. leakage when co-ex-
pressed in any combination regardless of whether DuoxA was
untagged, N-terminally 3FLAG-tagged, or C-terminally
3FLAG-tagged (Fig. 2A; data not shown). O2. release by
Duox2 with DuoxA1 or various types of N-terminally tagged
DuoxA2 was confirmed by examining the effect of superoxide
dismutase and/or through cytochrome c reduction assays (Fig.
2, A and B). The luminol  HRP assays were used to detect
gross ROS production (H2O2, O2. , and other non-identified
ROS) and to measure the ROS production capabilities in each
Duox-DuoxA pair. Immunoblotting was performed to confirm
comparable expression of constructs used (Fig. 2C). The results
of these assays suggested that altered interactions between
Duox2 and the N-terminal regions of its maturation factor,
DuoxA2, cause increased O2. leakage from this enzyme com-
plex; the same was not observed in case of Duox1.
The N-terminal Extracellular Region of DuoxA1 Plays a Piv-
otal Role in O2. Release—DuoxA proteins have four TM seg-
ments, and their N-terminal regions are positioned on the
extracytoplasmic membrane surface (6). When transported to
the plasmamembrane in complexeswithDuoxes, theN termini
of DuoxA proteins are detectable on the cell surface (7). To
confirm the importance of the N-terminal extracellular regions
of DuoxAs for O2. leakage, we made two chimeric mutants of
DuoxA1 and DuoxA2: DuoxA(1-2), in which the N-terminal
extracellular region of DuoxA2 was substituted with that of
DuoxA1, and DuoxA(2-1), in which the N-terminal extracellu-
lar region of DuoxA1was substituted with that of DuoxA2 (Fig.
TABLE 1
Summary of the Duox and DuoxA expression constructs used
PoxH, peroxidase homology; F, first half; S, second half; N, N terminus; C, C terminus; A, A-loop; C, C-loop; E, E-loop; FLAG-tagged constructs are in p3FLAG-CMV
vector and all other constructs in pcDNA3.1.
Name of protein Structures of expressed protein
Duox
Duox1 and Duox2 Wild type Duox1 and Duox2
2HA-Duox1 2HA tag between Asn-23 and Pro-24 of extracellular PoxH domain
2HA-Duox2 2HA tag between Asp-27 and Ala-28 of extracellular PoxH domain
Duox PoxH-domain chimera
Duox(1PoxH-2) Chimera of PoxH domain of Duox1 (1–592 aa) and Nox-like portion of Duox2 (596–1548 aa)
Duox(2PoxH-1) Chimera of PH domain of Duox2 (1–594 aa) and Nox-like portion of Duox1 (592–1551 aa)
DuoxA
DuoxA1 and DuoxA2 Wild type DuoxA1 and DuoxA2
3NxFLAG-DuoxA1 3xFLAG tag at the extracellular N terminus
DuoxA1–3CxFLAG 3xFLAG tag at the intracellular C terminus
DuoxA1–1CxFLAG 1xFLAG tag at the extracellular C-terminus
DuoxA1(N-del) The extracellular N terminus (2–17 aa) deletion
3NxFLAG-DuoxA2 3xFLAG tag at the extracellular N terminus
2NxFLAG-DuoxA2 2 FLAG tag at the extracellular N terminus
1NxFLAG-DuoxA2 1xFLAG tag at the extracellular N terminus
2NxHA-DuoxA2 2HA tag at the extracellular N terminus
DuoxA2–3CxFLAG 3xFLAG tag at the intracellular C terminus
DuoxA2(N-del) The extracellular N terminus (2–17 aa) deletion
DuoxA N-terminal chimera
DuoxA(1–2) Chimera of extracellular N terminus of DuoxA1 (1–19 aa) and DuoxA2 (20–320 aa)
DuoxA(2–1) Chimera of extracellular N terminus of DuoxA2 (1–19 aa) and DuoxA1 (20–343 aa)
DuoxA(1F-2) Chimera of DuoxA1 (1–8 aa; first half of 19aa) and DuoxA2 (9–320 aa)
DuoxA(2–1S-2) Chimera of DuoxA2 (1–11 aa), DuoxA1 (12–19 aa; second half of 19aa), and DuoxA2 (20–320 aa)
A-loop
Duox231(A:5aa) 5aa in A-loop of Duox2 is replaced by corresponding 5aa in A-loop of Duox1
Duox231(A:8aa) 8aa in A-loop of Duox2 is replaced by corresponding 8aa in A-loop of Duox1
Duox132(A:F4aa) 4aa (first half of 8aa) in A-loop of Duox1 is replaced by corresponding 4aa in A-loop of Duox2
Duox132(A:S4aa) 4aa (second half of 8aa) in A-loop of Duox1 is replaced by corresponding 4aa in A-loop of Duox2
Duox132(A:8aa) 8aa in A-loop of Duox1 replaced by corresponding 8aa in A-loop of Duox2
Duox132(A:8aaL) 8aa Arg in A-loop of Duox1 replaced by corresponding residues (8aa Leu) in A-loop of Duox2
Duox132(A:8aaGL) 8aa Ala and Arg in A-loop of Duox1 replaced by corresponding residues (8aa Gly and Leu) in A-loop of Duox2
Duox132(A:8aaL)L/A Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Leu to Ala
Duox132(A:8aaL)PP/HH Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Pro-Pro to His-His
Duox132(A:8aaL)PP/HP Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Pro-Pro to His-Pro
Duox132(A:8aaL)PP/PH Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Pro-Pro to Pro-His
Duox132(A:8aaL)D/G Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Asp to Gly
Duox132(A:8aaL)A/T Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Ala to Thr
Duox132(A:8aaL)Q/D Duox132 (A:8aa L) with reversed mutation (Duox2 to Duox1), Gln to Asp
Duox132(A:PPD) 3aa residues in A-loop of Duox1 are replaced by corresponding Pro,Pro and Asp residues in A-loop of Duox2
Duox-Nox(A-loop) chimera
Duox13Nox1(A) 7aa in A-loop of Duox1 replaced by corresponding residues in A-loop of Nox1
Duox13Nox5(A) 7aa in A-loop of Duox1 replaced by corresponding residues in A-loop of Nox5
Duox23Nox1(A) 7aa in A-loop of Duox2 replaced by corresponding residues in A-loop of Nox1
Duox23Nox5(A) 7aa in A-loop of Duox2 replaced by corresponding residues in A-loop of Nox5
C-loop
Duox231(C:10aa) 10aa (IVLAINVVNK) in C-loop of Duox2 replaced by corresponding 10 aa in C-loop of Duox1 (LIVSLGLHDE)
E-loop
Duox231(E:TY/RF) Thr and Tyr in E-loop of Duox2 replaced by corresponding Arg and Phe in E-loop of Duox1
Role of Duox A-loops in H2O2 Release
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3A).When co-expressedwithDuoxA(2-1), Duox2 exhibited no
O2. release (Fig. 3B); in contrast, when co-expressed with
DuoxA(1-2), Duox2 showed markedly enhanced O2. release
(Fig. 3B). To define the specific aa sequence in the N-terminal
extracellular region of DuoxA(1-2) that influences O2. release,
we made two additional chimeric mutants of DuoxA(1-2):
DuoxA(1F-2), in which only the first half of the N-terminal
extracellular region of DuoxA2 was substituted with that of
DuoxA1, and DuoxA(2-1S-2), in which only the second half of
the N-terminal extracellular region of DuoxA2 was substituted
with that of DuoxA1 (Fig. 3A). O2. release from Duox2 with
DuoxA(1F-2) or DuoxA(2-1S-2) was similar, at about one-third
that fromDuox2DuoxA(1-2) (Fig. 3B).Duox1withDuoxA(2-1)
or DuoxA(1-2) showed no O2. release (Fig. 3B). Comparable
expression of constructs was confirmed by immunoblotting (Fig.
3B). DuoxA1 pAb detected only WT DuoxA1 and not DuoxA1
chimeras. These results suggest that the entire N-terminal, extra-
cellular region of DuoxA1 has a strong influence on O2. release
when expressed in combination with Duox2.
The Extracellular Region(s) after the First TM Segment of
Duox2 Is Key to O2. Release—To explore the regions of Duox
involved in O2. release, we made two chimeric Duox mutants:
Duox(2PoxH-1), in which PoxH domain of Duox1 was substi-
tuted with that of Duox2, and Duox(1PoxH-2), in which the
PoxH domain of Duox2 was substituted with that of Duox1
(Fig. 4A). Three combinations, Duox2-DuoxA1, Duox(1PoxH-
2)-DuoxA1, and Duox(1PoxH-2)-DuoxA(1-2) (highlighted by
two-way red arrows in Fig. 4B), showed O2. release. All these
combinations contained the common Duox2 portion starting
with the first TM segment and the N-terminal extracellular
region of DuoxA1. Comparable expression of constructs was
confirmed by immunoblotting (Fig. 4B). These results suggest
that the extracellular region(s) after the first TM segment of
Duox2 and the N-terminal extracellular region of DuoxA1
affect O2. leakage.
The A-loops of Duoxes, but Not the C- or E-loops, Affect O2.
Release—To identify the extracellular region after the first TM
segment of Duox2 involved in O2. release in cooperation with
the N-terminal extracellular region of DuoxA1, we focused on
three extracellular regions of Duoxes, A-, C-, and E-loop (Fig.
1A). Because Duoxes, like all Nox enzymes, donate electrons to
molecular oxygen in the extracytoplasmic compartment, we
did not examine the roles of the intracellular EF-handmotifs or
the B- or D-loops in O2. release. These loops were defined in
reference to previous papers (4, 23) and using websites that
predict the secondary structures ofmembrane proteins (SOSUI
WWW Server; TMHMM Server). We hypothesized that if a
particular extracellular loop of Duox2 was involved in O2.
release, then chimeric mutants in which this loop of Duox2 is
replaced with that of Duox1 would exhibit reduced O2. leakage.
To explore this hypothesis, we firstmade two chimericmutants
of Duox2 possessing the A-loop sequences of Duox1:
Duox231(A:5aa) andDuox231(A:8aa) (Fig. 5A). O2. release by
Duox231(A:5aa)-DuoxA1 and Duox231(A:8aa)-DuoxA1
was dramatically reduced relative to the Duox2-DuoxA1 com-
plex (2.27 0.81% and 0.83 0.38%, respectively; Fig. 5B). To
confirm these results, we made three reverted chimeric
mutants of Duox1 possessing some A-loop sequence
FIGURE 2.O2
. leakage fromDuox2 paired with N-terminally tagged DuoxA2. A, Various Duox and DuoxA pairs were transfected into HEK293 cells. O2
. and
reactive oxygen speciesweremeasuredby chemiluminescence assay usingDiogenes and luminolHRP, respectively. Duox2 various types of N-terminally,
but notC-terminally, taggedDuoxA2, showenhancedO2
. production. The superoxidedismutase (SOD) treatmentwasperformed to validate theO2
. production
for those samples where marked O2
. production was observed. B, various Duox and DuoxA pairs were transfected into HEK293 cells, and O2
. was measured by
cytochrome c reduction assay. NADPH oxidase 1-based O2
. production was used as a positive control. All the samples were subjected to the superoxide
dismutase treatment, except for Duox2-DuoxA2. C, immunoblotting detects expression levels of Duox2 andDuox1 in various pairs aswell as the expression of
FLAG- and HA-tagged DuoxAs.
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from Duox2: Duox132(A:F4aa), Duox132(A:S4aa), and
Duox132(A:8aa) (Fig. 5A). Although Duox132(A:F4aa) and
Duox132(A:S4aa) showed no O2. release, Duox132(A:8aa)
co-expressed with DuoxA1 did show O2. release (67.4  8.9%)
but to a lesser extent than that by Duox2-DuoxA1 (Fig. 5B).
Duox132(A:8aa) maintained capabilities to secret H2O2,
which were detected by Amplex Red  HRP, as in the case of
Duox1 and Duox2 (Fig. 5B). We then made two additional
Duox1 mutants: Duox132(A:8aaL) and Duox132(A:
8aaGL) (Table 1). In Duox132(A:8aaGL), the entire
A-loop aa sequence of Duox1 was replaced with that of Duox2.
O2. release fromDuox132(A:8aaL)-DuoxA1 (146.9 16.7%)
and Duox132(A:8aaGL)-DuoxA1 (101.4 19.3%) matched
that from Duox2-DuoxA1 (Fig. 5C); therefore, Duox132(A:
8aaL) was used for further studies.
To examine which aa residues in the A-loop of Duox1 are
critical for the reduction of O2. release, we made various
mutants in which one or two aa residues in the A-loop of
Duox132(A:8aaL) were reverted to those of Duox1. Chang-
ing Pro1068-Pro1069 into His-His (PP/HH) and Asp1071 into Gly
(D/G) almost completely abolished O2. release (ROS produc-
tion detected by luminol  HRP was 57.4  8.3% and 54.9 
6.9%, respectively). In contrast, changing Leu1067 into Ala
(L/A), Ala1073 into Thr (A/T), and Gln1074 into Asp (Q/D)
caused moderate effects. Replacement of either Pro residue
with His was sufficient to abolish O2. release by Duox132(A:
FIGURE 3. O2
. leakage from Duox2 paired with DuoxAs with the N-termi-
nal extracellular region of DuoxA1. A, illustration showing DuoxA1,
DuoxA2, and four chimeric DuoxA proteins: DuoxA(1-2), DuoxA(2-1),
DuoxA(1F-2), and DuoxA(2-1S-2). B, various Duox and DuoxA pairs were
transfected into HEK293 cells. O2
. , and reactive oxygen species were mea-
sured by chemiluminescence assay using Diogenes and luminol  HRP,
respectively. Duox2  DuoxAs with the N-terminal extracellular region of
DuoxA1 showO2
. production in the followingorder: DuoxA(1-2)DuoxA(1F-
2)DuoxA(2-1S-2). Immunoblotting detected the expression of Duoxes and
DuoxAs. A pAb against Duoxes preferentially reacts with Duox2 via its first
intracellular loop but also faintly detects Duox1 (the last two lanes). A pAb for
DuoxA1,which reactswith its extracellular N terminus, only detectswild-type
DuoxA1.
FIGURE 4. O2
. leakage from pairs of Duoxes with the Nox-like portion of
Duox2 and DuoxAs with the N-terminal extracellular region of DuoxA1.
A, illustration showing Duox1, Duox2, and two chimeric Duox proteins:
Duox(1PoxH-2) and Duox(2PoxH-1). B, various Duox and DuoxA pairs were
transfected into HEK293 cells. O2
. and total reactive oxygen species were
measured by chemiluminescence assay using Diogenes and luminol HRP,
respectively. Pairs (red arrows) with the Duox2 portion after the first trans-
membrane segment (termed the Nox-like portion) DuoxA with the N-ter-
minal extracellular region of DuoxA1 show O2
. production. Immunoblotting
detects the expression levels of various Duox andDuoxA pairs. A pAb against
Duoxes faintlydetectedDuox2chimeras in the two right-hand lanes. ApAb for
DuoxA1 detects only wild-type DuoxA1.
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FIGURE5.TheA-loopofDuox isassociatedwithO2
. leakage.A, alignmentof theA-loopsofDuox1andDuox2.Theupper (blue) and lower (red) illustrations indicate
the changes in aa sequence (number and residue) of theA-loop fromDuox2 toDuox1 (Duox231(A)) and those fromDuox1 toDuox2 (Duox132(A)), respectively. B,
various pairs, includingDuox231(A:5aa) or Duox231(A:8aa)DuoxA, Duox132(A:F4aa), Duox132(A:S4aa), or Duox132(A:8aa)DuoxA, were transfected into
HEK293 cells. O2
. , reactive oxygen species, and H2O2 weremeasured by chemiluminescence assay using Diogenes, luminolHRP, and Amplex RedHRP, respec-
tively.NeitherDuox231(A:5aa)norDuox231(A:8aa)showssignificantO2
. production. Incontrast,Duox132(A:8aa),butnotDuox132(A:F4aa)orDuox132(A:S4aa),
gained theability toproduceO2
. ,which is abolishedby theadditionof superoxidedismutase. Immunoblottingdetects comparable expression levels of variousDuox
and DuoxA pairs. C, various pairs of Duox132(A)  DuoxA were transfected into HEK293 cells. O2
. was measured by chemiluminescence assay using Diogenes.
Duox13(A:8aaL)DuoxA1showsthehighestO2
. production.PP/HHorD/GmutationsabolishO2
. productionbyDuox132(A:8aaL).Duox132(A:PPD)DuoxA
shows no ability to produceO2
. . Immunoblotting detects expression levels of various Duox andDuoxA pairs.
FIGURE 6. Kinetics of O2
. and ROS production. A, various pairs, including HA-Duox2-DuoxA2, HA-Duox2-DuoxA2(N-del), HA-Duox231(A:8aa)-DuoxA2,
HA-Duox1-DuoxA1, HA-Duox231(A:8aa)-DuoxA1, HA-Duox132(A:8aaL)-DuoxA1, and HA-Duox2-DuoxA1, were transfected into HEK293 cells. Represen-
tative (n 3) kinetics of O2
. and reactive oxygen species productionmeasured by chemiluminescence assay using Diogenes and luminolHRP, respectively,
are shown. B, immunoblotting detects comparable expression levels of various Duox and DuoxA pairs.
Role of Duox A-loops in H2O2 Release
MARCH 6, 2015•VOLUME 290•NUMBER 10 JOURNAL OF BIOLOGICAL CHEMISTRY 6501
 at SEM
M
ELW
EIS U
N
IV
 O
F M
ED
ICIN
E on February 28, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
8aaL); this was confirmed using PP/HP and PP/PH muta-
tions in Duox132(A:8aaL) (data not shown). In addition,
although the expression levels of Duox132(A:PPD), in
which three critical residues (HHG) in the A-loop of
Duox1 were exchanged for those of Duox2, were apparently
low (ROS production detected by luminolHRP was 36.8
10.8%), it showed no O2. release (Fig. 5C). Taken together,
these results suggest that these specific residues alone do not
account for the function of the Duox A-loop in preventing
O2. release. Comparable expression of constructs was con-
firmed by immunoblotting (Fig. 5, B and C).
Next, we examined the kinetics of O2. and ROS production
(detected by Diogenes and luminol  HRP, respectively) from
various Duox  DuoxA pairs: Duox2-DuoxA2, Duox2-
DuoxA2(N-del), Duox231(A:8aa)-DuoxA2, Duox1-DuoxA1,
Duox231(A:8aa)-DuoxA1, Duox132(A:8aaL)-DuoxA1,
and Duox2-DuoxA1. Duox132(A:8aaL)-DuoxA1 and Duox2-
DuoxA1 showed very similar kinetic curves in terms of both
O2. and ROS production (Fig. 6A). Duox231(A:8aa)-DuoxA1
showed a kinetic curve of ROS production similar to that of
Duox1-DuoxA1 (Fig. 6A). Duox2-DuoxA2(N-del) showed an
increase inO2. releaseandadecrease inROSproductioncompared
withDuox2-DuoxA2 (Fig. 6A).Duox231(A:8aaL)-DuoxA2did
not show any O2. release (Fig. 6A). In the Duox1-DuoxA1(N-del)
pair,ROSproductionwasseverely impaired (10%thatofDuox1-
DuoxA1), and no apparent plasma membrane targeting/localiza-
tion of Duox1 or O2. release was observed (data not shown).
Comparable expression of constructs was confirmed by immuno-
blotting (Fig. 6B).
Finally, we assessed the involvement of the C- and E-loops in
O2. release using chimeric mutants in which their sequences in
Duox2 were replaced with those of Duox1 (Fig. 7, A and C).
O2. release was not reduced in either the C-loop mutant,
Duox231(C:10aa), or the E-loopmutant, Duox231(E:TY/RF)
(Fig. 7, B and D). Comparable expression of constructs was
confirmed by immunoblotting (Fig. 7, B and D). Taken
together, we conclude that theA-loop, but not theC- or E-loop,
of Duox2 is involved in O2. release.
FIGURE7.TheC-andE-loopofDuoxarenotassociatedwithO2
. leakage.A, alignmentof theC-loopsofDuox1andDuox2and illustrationsof chimericDuox2
mutants indicating the residue and number of amino acids changes in the C-loop fromDuox2 to Duox1 (Duox231(C)). B, Duox231(C:10aa) and DuoxA pairs
were transfected into HEK293 cells. O2
. and ROS were measured by chemiluminescence assays using Diogenes and luminol  HRP, respectively. The
Duox231(C:10aa)DuoxA pairs show no decreasedO2
. production. Immunoblotting (from the samemembrane and image) detects comparable expression
levels of various Duox and DuoxA pairs. C, alignment of the E-loops of Duox1 and Duox2 and illustrations of chimeric Duox2 mutants indicating the residues
change in the E-loops from Duox2 to Duox1 (Duox231(E)). D, Duox231(E:TY/RF) and DuoxAs pairs were transfected into HEK293 cells. O2
. and ROS were
measured by chemiluminescence assay using Diogenes and luminol  HRP, respectively. The Duox231(E:TY/RF)  DuoxA pairs show no decreased O2
.
production. Immunoblotting detects comparable expression levels of various Duox and DuoxA pairs.
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The A-loops of Both Duox1 and Duox2 Function in Reducing
O2. Leakage—To further investigate the mechanism underlying
the reduction of O2. release by the Duox A-loop, we made chi-
meric Duox proteins possessing the A-loops of Nox1 or Nox5
(23, 32) (Fig. 8A). Duox2 possessing the A-loop of Nox1 or
Nox5 showed markedly enhanced O2. release in matched com-
bination with DuoxA2 in comparison with the native Duox2-
DuoxA2 complex (Fig. 8B), suggesting that the A-loop of
Duox2 also functions in the reduction of O2. release. Further-
more, Duox1 possessing the A-loop of Nox1 or Nox5 exhibited
O2. release even whenmatched with DuoxA1 (Fig. 8B). Compa-
rable expression of constructs was confirmed by immunoblot-
ting (Fig. 8B). Taken together, these observations imply that the
A-loops of both Duox1 and Duox2 function in reducing O2.
release, although it appears that the A-loop of Duox1 is more
effective in reducing O2. release.
Stable and Mature Duox-DuoxA Complex Formation Is
Required forH2O2Production—Toexamine the hypothesis that
theA-loops of Duoxes have the intrinsic ability to convertO2. to
H2O2, we synthesized oligopeptides of the A-loops of Duox1
and Duox2. We performed the following experiments: 1) add-
ing A-loop peptides into xanthine oxidase reactions generating
O2. to detect its conversion and 2) adding A-loop peptides into
Diogenes-based O2. assays in heterologous Duox-reconstituted
cell systems. However, these experiments failed to reduce O2.
production (data not shown), suggesting that the A-loops of
Duoxes have no O2. dismutation activity.
Next, we investigated possible direct interaction between the
biotin-labeled A-loop peptides of Duoxes and the GST-tagged
N-terminal extracellular sequences of the DuoxAs by pulldown
assays using streptavidin-conjugated magnetic beads. We
detected the strongest interaction between Duox1(Aloop) and
DuoxA1(N) among Duox1(Aloop)-DuoxA1(N), Duox2(Aloop)-
DuoxA2(N), Duox1(Aloop)-DuoxA2(N), and Duox2(Aloop)-
DuoxA1(N) pairs (Fig. 9).
We then focused on the interaction between full-length
Duoxes and DuoxAs at the cellular level because our previous
paper established thatDuoxmaturation, reflected inN-glycosyl
modifications and stable interactions with DuoxAs, affects the
type of ROS produced in that fully processed and stable com-
plexes do not leak O2. (7). The relationship between O2. release
and Duox binding to DuoxAs was examined by immunopre-
cipitation assays using lysates from HEK293 cells transfected
with various Duox and DuoxA combinations. The order of the
strength of Duox2 binding to FLAG-tagged DuoxAs was
3NFLAG-DuoxA2  DuoxA1–3CFLAG  DuoxA2–
3CFLAG (Fig. 10A). This order inversely correlated with the
amount of O2. release by the Duox2 complex: 3NFLAG-
DuoxA2  DuoxA1–3CFLAG  DuoxA2–3CFLAG (Fig.
10A). The order of the strength of DuoxA1 binding to HA-
tagged Duoxes was HA-Duox132(A:8aaL)  HA-Duox2 
HA-Duox1  HA-Duox231(A:8aa) (Fig. 10B). This order
also inversely correlated with the amount of O2. release:
HA-Duox132(A:8aa L)  HA-Duox2  HA-Duox1 
HA-Duox231(A:8aa) (Fig. 10B), suggesting that stable interac-
tions between Duoxes and DuoxAs prevent O2. release. Com-
parable plasmamembrane targeting/localization of these seven
pairs was statistically confirmed by the nonpermeable immu-
nostaining of HA-tagged Duoxes using an Alexa Fluor 488-
conjugated HA mAb (data not shown).
To explore the relationship betweenDuoxmaturation (Golgi
apparatus-based glycosyl modifications) and O2. release, Endo
H treatments were performed. Duox2-DuoxA1 complexes that
showedO2. release was sensitive to EndoH treatment (Fig. 10C,
FIGURE 8. TheA-loops of bothDuox1 andDuox2 preventO2
. leakage. The
illustrations indicate changes in the core aa sequences of the A-loops (7 aa)
from Duoxes to Nox (1 or 5). Green and purple colors indicate the changes
from Duox2 to Nox1 or Nox5 (Duox23Nox(A)) and those from Duox1 to
Nox1 or Nox5 (Duox13Nox(A)), respectively. Various pairs were transfected
into HEK293 cells. O2
. was measured by a chemiluminescence assay using
Diogenes. Immunoblotting detects comparable expression levels of various
Duox and DuoxA pairs.
FIGURE 9. Direct binding of the Duox A-loop to the DuoxA N terminus.
Purified GST-tagged DuoxA N terminus was mixed with synthesized biotin-
labeled Duox A-loop in binding buffer. IP, immunoprecipitation. Then,
streptavidin-coupled magnetic beads were added 2 h later. The material
absorbed to thebeadswaseluted inLaemmli samplebuffer. Theeluentswere
subjected to SDS-PAGE followed by immunoblotting (WB) using a polyclonal
antibody against GST. The strongest interaction was observed between
Duox1(Aloop) and DuoxA1(N) relative to Duox2(Aloop)  DuoxA2(N),
Duox1(Aloop) DuoxA2(N), and Duox2(Aloop) DuoxA1(N) (n 3).
Role of Duox A-loops in H2O2 Release
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left). Interestingly, although the Duox132(A:8aaL)-DuoxA1
complex showed glycosyl modifications of Duox132(A:
8aaL) similar to that of Duox1 in the Duox1-DuoxA1 com-
plex, theDuox132(A:8aaL)-DuoxA1 complex that exhibited
O2. release was also susceptible to Endo H treatment (Fig. 10C,
right). Conversely, Duox231(A:8aa)-DuoxA1, which pro-
duced H2O2 but no O2. , was resistant to Endo H treatment (Fig.
10C, right). Taken together, these results suggest that the
A-loop of Duox1 functions to promote the formation of stable
and mature Duox1-DuoxA1 complexes, preventing O2. release.
DISCUSSION
Duox enzymes serve as dedicated H2O2 generators at the
plasma membrane, where they support the activities of extra-
cellular hemoperoxidases (22). We (7) and another group (26)
previously reported a switch in the type of ROS released, from
H2O2 to O2. , with co-expression of the mismatched Duox2 and
DuoxA1 pair, but not with Duox1 and DuoxA2 (7). These find-
ings suggest that DuoxA proteins contribute to Duox matura-
tion and subcellular targeting; they also function as a part of the
ROS-generating complex. Subsequently, Hoste et al. (31)
showed that the N terminus of DuoxA2 acts as an important
determinant of the type of ROS produced byDuox2 by compar-
ing native DuoxA2 with N-terminally truncated and chimeric
versions of DuoxA2 and DuoxA1. Consistent with our results,
they showed that 1) the addition of tags of various types and
lengths to the N-terminal of DuoxA2 increased the amount of
O2. leakage by Duox2 (rhodopsin (19 aa) and FLAG (8 aa) tags
(31); FLAG (22 aa in 3NFLAG, 15 aa in 2NFLAG, and 8 aa in
1NFLAG), and 2NHA (20 aa) tags (this study)) and 2) a
small amount of O2. is released by the native Duox2-DuoxA2
complex but not by the Duox1-DuoxA1 or Duox1-DuoxA2
complexes (31).
In this study we expanded upon these observations on ROS
generation by Duoxes by identifying novel structural determi-
nants within the Nox-like extracellular portion of Duoxes,
termed the A-loop, that appears to function in preventing O2.
leakage by supporting the stabilization and maturation of the
FIGURE 10. The A-loop of Duox is associated with binding to DuoxA, O2
. leakage, and Endo H-resistant N-glycosyl modification. A and B, HA-tagged
Duox2 various types of FLAG-tagged DuoxA (A) or various types of HA-DuoxDuoxA1–1CFLAG (B) were transfected into HEK293 cell. Forty-eight hours
after transfection lysates were immunoprecipitated (IP) by a magnetic agarose-conjugated HA mAb followed by immunoblotting (WB) using an HRP-conju-
gated FLAGmAb. Representativedata (n3) showgoodcorrelationbetweenaweak interactionbetweenDuox andDuoxAandhighO2
. production.C, various
HA-tagged Duox and DuoxA pairs were transfected into HEK293 cell. Forty-eight hours after transfection lysates were treated with Endo H, and immunoblot-
ting was performed using an HRP-conjugated HA mAb. Representative data (n  3) show the presence of Endo H-sensitive bands in O2
. producing pairs
(HA-Duox2 DuoxA1 and HA-Duox132(A:8aaL) DuoxA1).
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Duox-DuoxA complex. Although the A-loop of Duox1 is more
effective at preventing O2. leakage than that of Duox2, the
A-loops of both the Duox isozymes function in preventing O2.
release (Fig. 8). A recent study (33) showed that Nox4 has a
unique extracellular E-loop, longer than that in other Nox fam-
ily proteins, which was proposed to hinder O2. release and facil-
itate its conversion to H2O2. Interestingly, this study high-
lighted the importance of His222 of Nox4, proposing that this
conserved residue serves as a source of protons for O2. dismu-
tation. However, we found that neither the E-loop nor the
C-loop aa sequences of either Duox influenced O2. release by
Duox-DuoxA complexes. The PoxHdomain ofDuoxes is a can-
didate for intramolecularO2. dismutation, although the isolated
domains of both Duox isozymes did not demonstrate superox-
ide dismutase or peroxidase activity in vitro (24, 25). In this
study we observed reduced O2. release by Duox(1PoxH-2)-
DuoxA1 than by Duox2-DuoxA1 (Fig. 4), suggesting that the
PoxH domain of Duox1 could reduce O2. leakage by supporting
its conversion to H2O2. Three residues in the A-loop of Duox1
(HH and G) critical for the reduction of O2. leakage are highly
conserved in Duox1 in many species (Fig. 11), and the corre-
sponding PP residues in the A-loop of Duox2 are also well con-
served inmany species. TheA-loop sequences of humanDuox1
and Duox2 have different predicted secondary structures as
analyzed by several structural modeling algorithms (cfPred:
Chou-Fasman Protein Secondary Structure Predictor), sug-
gesting that the A-loops of Duox1 and Duox2 interact differ-
ently with other structures involved in the conversion of O2. to
H2O2 (i.e. theDuoxAN termini orDuox PoxHdomains). These
structural differences may explain the observed differences in
O2. leakage, complex stability, and maturation. The A-loops of
Nox1 and Nox5, which produce O2. , also lack HH residues and
are even more divergent, consistent with their effects in induc-
ing or enhancing O2. release by chimeric Duox1 or Duox2 pro-
teins, respectively (Fig. 8). Moreover, the compound heterozy-
gous mutation of Duox2(L1067S) in the A-loop combined with
otherDuox2mutationswas identified in patientswith transient
congenital hypothyroidism (12), further supporting the impor-
tance of the A-loop structure to Duox function.
We found direct binding of the A-loops of Duoxes to the N
termini of DuoxAs in vitro (Fig. 9). In addition, the strength of
the interaction between the Duox and DuoxA pairs at the cel-
lular level inversely correlated with the amount of O2. released-
weaker interactions correlated with greater O2. leakage (Fig. 10,
A and B). Furthermore, the A-loop of Duox1 induced complete
Endo H-resistant glycosyl modifications of Duoxes (Fig. 10C).
To determine whether glycosyl modifications of Duoxes affect
ROS production and O2. leakage, we created glycosylation-de-
fective mutants of untagged and HA-tagged human Duox1 and
Duox2 in which all five putative glycosylation sites (4) (Asn-94,
-342, -354, -461, and -534 in Duox1; Asn-100, -348, -382, -455,
and -537 in Duox2) were replaced by Gln. In Duox-reconsti-
tuted HEK293 cell systems, these mutants showed severely
impaired glycosylation (almost no band shift in Duoxes upon
immunoblotting), plasma membrane targeting/localization of
the Duox-DuoxA complex, and ROS production or O2. leakage
detected by luminol  HRP or Diogenes (data not shown).
Taken together, these results suggest that 1) binding of the
A-loop of Duox1 to the N terminus of DuoxA1 contributes
to the enhanced interaction between Duox1 and DuoxA1
observed at the cellular level, thereby inducing more stable,
mature Duox-DuoxA complexes than those involving Duox2,
and 2) glycosyl modifications of Duoxes are essential for the
targeting/localization of the Duox-DuoxA complex to the
plasma membrane, increasing the stability of the Duox-DuoxA
complex and developing capabilities for ROS production
(including O2. leakage) on the plasma membrane. The forma-
tion of more stable Duox-DuoxA heterodimers or structural
changes associated with maturation, which are probably
acquired at the final destination, the apical cell surface, may
create an environment that more efficiently supports ROS con-
version and prevents O2. leakage.
In conclusion, in this study we demonstrated that the A-loop
of Duoxes is an important structural determinant that interacts
with the N termini of DuoxAs and facilitates the conversion of
O2. to H2O2, likely through mechanisms promoting the stabili-
zation and maturation of Duox-DuoxA complexes. Further
studies are required to unveil the detailed mechanisms under-
lying the intramolecular conversion ofO2. toH2O2 by theDuox-
DuoxA complex.
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